Carmen Roberts
Family Medicine · Manning, SCNPI 1659722411
Payments from drug & device makers
Across 266 payments — averaging $19.35 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AstraZeneca$980
- Novartis$558
- Amgen$495
- AbbVie$441
- Novo Nordisk$398
- Lilly USA, LLC$340
- plus $2K from 30 others
What the payments were for
- Food & beverage$5,146100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AstraZeneca | 43 | $980 |
| Novartis | 30 | $558 |
| Amgen(2 entities) | 23 | $495 |
| AbbVie(2 entities) | 28 | $441 |
| Novo Nordisk | 22 | $398 |
| Lilly USA, LLC | 22 | $340 |
| Merck | 12 | $220 |
| Boehringer Ingelheim | 9 | $174 |
| Johnson & Johnson | 10 | $165 |
| Sanofi-aventis U.S. LLC | 5 | $141 |
| Exact Sciences | 8 | $138 |
| Esperion Therapeutics, Inc. | 4 | $107 |
| Abbott | 5 | $94 |
| Bayer | 6 | $87 |
| Corcept Therapeutics | 3 | $72 |
| Pfizer | 3 | $63 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 3 | $62 |
| Eisai Inc. | 3 | $57 |
| Phathom Pharmaceuticals, Inc. | 4 | $55 |
| Mylan Specialty L.p. | 3 | $53 |
| Neuraxis, Inc. | 1 | $47 |
| Astellas Pharma US Inc | 2 | $45 |
| Renalytix AI, Inc. | 2 | $44 |
| Dexcom, Inc. | 1 | $37 |
| E.r. Squibb & Sons, L.L.C. | 2 | $37 |
| Amarin Pharma, Inc. | 2 | $32 |
| Axsome Therapeutics, Inc. | 1 | $28 |
| GSK | 1 | $27 |
| Smith+Nephew | 1 | $25 |
| Supernus Pharmaceuticals, Inc. | 1 | $23 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 1 | $20 |
| Medicure Pharma Inc. | 1 | $19 |
| Tactile Systems Technology Inc | 1 | $16 |
| Edwards Lifesciences | 1 | $15 |
| Daiichi Sankyo Inc. | 1 | $15 |
| Cvrx, Inc. | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$5,146 in reported general payments places this provider in the 85th percentile of 2,153 family medicine providers in South Carolina.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| MounjaroTirzepatide | 111 | $124,659 |
| EliquisApixaban | 78 | $76,832 |
| TrulicityDulaglutide | 71 | $74,382 |
| OzempicSemaglutide | 73 | $69,505 |
| FarxigaDapagliflozin Propanediol | 64 | $58,737 |
| JardianceEmpagliflozin | 65 | $57,369 |
| RybelsusSemaglutide | 30 | $41,175 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 28 | $27,728 |
| JanuviaSitagliptin Phosphate | 12 | $16,426 |
| VraylarCariprazine Hcl | 11 | $15,918 |
| Breztri AerosphereBudesonide/Glycopyr/Formoterol | 24 | $15,585 |
| Repatha SureclickEvolocumab | 15 | $12,420 |
| MyrbetriqMirabegron | 12 | $11,331 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 110 | $3,157 |
| Atorvastatin Calcium | 209 | $2,696 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Lilly USA, LLCMounjaro, Trulicity, Humulin 70-30 | $340 | $200,255195 claims |
| Novo NordiskOzempic, Rybelsus | $398 | $110,680103 claims |
| PfizerEliquis | $63 | $76,83278 claims |
| AstraZenecaFarxiga, Breztri Aerosphere | $980 | $74,32188 claims |
| Boehringer IngelheimJardiance | $174 | $57,36965 claims |
| GSKTrelegy Ellipta | $27 | $27,72828 claims |
| AbbVieVraylar, Synthroid | $441 | $17,51537 claims |
| MerckJanuvia | $220 | $16,42612 claims |
| Astellas Pharma US IncMyrbetriq | $45 | $11,33112 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 2,153 family medicine providers in South Carolina.
Other family medicine in Manning
- Cayce TangemanGoose Creek$8.4M
- Jeremy AckermannMoncks Corner$7.6M
- Kelly MoralesNorth Charleston$6.5M
- William ByarsGreer$4.8M
- James FranklinGreenville$3.5M
- Stephen GrubbLittle River$3.4M
- Jeffrey HarrisGreenville$3.4M
- Shannon ConradN Charleston$3.3M
- Tom ChristensenLittle River$3.1M
- Edward NewtonCharleston$3M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.